Wanja Bernhardt

发表

Diverse molecular causes of unsolved autosomal dominant tubulointerstitial kidney diseases.

K. Stark, A. Ekici, Markus Gödel, 2022, Kidney international.

Severe neurological outcomes after very early bilateral nephrectomies in patients with autosomal recessive polycystic kidney disease (ARPKD)

M. Marlais, M. Litwin, L. Weber, 2020, Scientific Reports.

Risk Factors for Early Dialysis Dependency in Autosomal Recessive Polycystic Kidney Disease

A. Anarat, S. Schmidt, S. Testa, 2018, The Journal of pediatrics.

Early childhood height-adjusted total kidney volume as a risk marker of kidney survival in ARPKD

M. Marlais, L. Weber, D. Mekahli, 2021, Scientific Reports.

Role of hypoxia in the pathogenesis of renal disease.

Kai-Uwe Eckardt, K. Eckardt, M. Wiesener, 2005, Kidney international. Supplement.

Pentraxin 3 is elevated in haemodialysis patients and is associated with cardiovascular disease.

R. Schindler, M. Boehme, C. Fischer, 2007, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Sparsentan in patients with IgA nephropathy: a prespecified interim analysis from a randomised, double-blind, active-controlled clinical trial

Eddie B. S. Tan, Nishit P. Parikh, Rajan K. Patel, 2023, The Lancet.

H. Haller, G. Einecke, G. Schlieper, 2021, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.